Literature DB >> 24472473

Risk factors for in-hospital mortality and prolonged length of stay in older patients with solid tumor malignancies.

Michelle Shayne1, Eva Culakova2, Marek S Poniewierski2, David C Dale3, Jeffrey Crawford2, Adane F Wogu2, Gary H Lyman4.   

Abstract

OBJECTIVE: Hospitalized adult patients with cancer and with major comorbidities have higher mortality rates and longer duration of hospitalization. There is limited understanding of risk factors that contribute to prolonged hospitalization and mortality in older patients with solid tumors.
MATERIALS AND METHODS: Risk factors associated with in-hospital mortality and prolonged length of stay (LOS) in older patients with cancer were investigated in a retrospective cohort study. Data from the University HealthSystem Consortium database included 386,377 patients age ≥ 65 years with solid tumors hospitalized between 1995 and 2003 at 133 U.S. academic medical centers.
RESULTS: The overall mortality rate was 7.3%. Mortality in older patients with cancer was strongly associated with longer LOS. Almost twice as many deaths were observed among those with LOS ≥ 10 days (p<0.0001). Nearly 38% of older cancer patients who died in hospital had potentially curable disease. Primary central nervous system malignancies were most strongly associated with in-hospital mortality (OR=1.81; 1.59-2.07), followed by esophageal (OR=1.74; 1.54-1.97) and lung cancer (OR=1.57; 1.43-1.72). Male gender, African-American race, and Hispanic and Asian race/ethnicity were associated with increased risk of mortality (p<0.0001). Additional risk factors included metastatic disease, infection, neutropenia, renal, lung, hepatic, cerebrovascular disease, arterial/venous thromboembolism, heart failure, and red blood cell transfusion. Risk factors for prolonged LOS included gastric cancer, infection, venous thromboembolism and red blood cell transfusion.
CONCLUSIONS: Prolonged LOS was strongly associated with mortality. Risk factors such as infection, neutropenia and red blood cell transfusion, when modified, could potentially reduce rates of prolonged LOS and mortality in older patients with cancer.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cancer; Elderly; Hospitalization; Mortality

Mesh:

Year:  2013        PMID: 24472473     DOI: 10.1016/j.jgo.2013.05.005

Source DB:  PubMed          Journal:  J Geriatr Oncol        ISSN: 1879-4068            Impact factor:   3.599


  6 in total

1.  Comparative effectiveness of surgery and radiosurgery for stage I non-small cell lung cancer.

Authors:  James B Yu; Pamela R Soulos; Laura D Cramer; Roy H Decker; Anthony W Kim; Cary P Gross
Journal:  Cancer       Date:  2015-04-06       Impact factor: 6.860

2.  Application of DMAIC Cycle and Modeling as Tools for Health Technology Assessment in a University Hospital.

Authors:  Alfonso Maria Ponsiglione; Carlo Ricciardi; Arianna Scala; Antonella Fiorillo; Alfonso Sorrentino; Maria Triassi; Giovanni Dell'Aversana Orabona; Giovanni Improta
Journal:  J Healthc Eng       Date:  2021-08-17       Impact factor: 2.682

Review 3.  Hospitalists caring for patients with advanced cancer: An experience-based guide.

Authors:  Douglas J Koo; Emily S Tonorezos; Chhavi B Kumar; Tabitha N Goring; Cori Salvit; Barbara C Egan
Journal:  J Hosp Med       Date:  2015-11-20       Impact factor: 2.960

4.  Enhanced recovery after surgery (ERAS) pathway for primary hip and knee arthroplasty: study protocol for a randomized controlled trial.

Authors:  Jingyi Li; Haibei Zhu; Ren Liao
Journal:  Trials       Date:  2019-10-22       Impact factor: 2.279

5.  Early spot sign is associated with functional outcomes in primary intracerebral hemorrhage survivors.

Authors:  Wen-Che Tseng; Yu-Fen Wang; Tyng-Guey Wang; Ming-Yen Hsiao
Journal:  BMC Neurol       Date:  2021-03-20       Impact factor: 2.474

6.  Outcomes of Patients Placed in an Emergency Department Observation Unit of a Comprehensive Cancer Center.

Authors:  Patrick Chaftari; Demis N Lipe; Monica K Wattana; Aiham Qdaisat; Pavitra P Krishnamani; Jomol Thomas; Ahmed F Elsayem; Marcelo Sandoval
Journal:  JCO Oncol Pract       Date:  2021-12-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.